8-KEarnings & ResultsExhibits & Filings

VERTEX PHARMACEUTICALS INC / MA 8-K Report, Financial Results (Jul 30, 2012)

Filed July 30, 2012For Securities:VRTX

Summary

Vertex Pharmaceuticals Incorporated filed a Form 8-K on July 30, 2012, to report its consolidated financial results for the quarter ended June 30, 2012. The primary purpose of this filing is to provide investors with timely information regarding the company's financial performance and condition. The report includes a press release, attached as Exhibit 99.1, which details the company's financial results. While the 8-K itself does not provide the specific figures, it directs investors to the accompanying press release for comprehensive details on revenue, earnings, and other key financial metrics for the second quarter of 2012. Investors should review this press release for a deeper understanding of Vertex's operational and financial standing.

Key Highlights

  • 1Vertex Pharmaceuticals Inc. filed an 8-K on July 30, 2012.
  • 2The filing reports consolidated financial results for the quarter ended June 30, 2012.
  • 3The key financial information is contained within an attached press release (Exhibit 99.1).
  • 4This 8-K serves as a formal notification of the company's quarterly financial results.
  • 5Investors are directed to the press release for specific financial details.
  • 6The report's information is not deemed 'filed' for Section 18 liability purposes unless explicitly incorporated by reference into other filings.
  • 7The filing was made on the event date of July 29, 2012, indicating timely disclosure.

Frequently Asked Questions

The main purpose of this Form 8-K filing is to officially report Vertex Pharmaceuticals' consolidated financial results for the quarter ended June 30, 2012, and to make these results available to investors and the public.

The specific financial results for the quarter ended June 30, 2012, are detailed in the press release dated July 30, 2012, which is attached as Exhibit 99.1 to this Form 8-K filing. You should refer to that press release for detailed figures.

This 8-K filing itself primarily announces that the financial results have been released and directs readers to the attached press release for the details. While the press release contains the financial results, the 8-K form's Item 2.02 mainly references the press release rather than including the full financial statements directly within the 8-K form itself.

This means that the press release attached to the 8-K is generally not subject to the strict liability provisions of Section 18 of the Securities Exchange Act of 1934. However, it can still be incorporated by reference into other SEC filings, such as registration statements, which would then subject it to those provisions.